A PhaseⅠ Study of HW252001 in Healthy Subjects

NCT07493031 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

98

Enrollment

INDUSTRY

Sponsor class

Conditions

IPF

Interventions

DRUG: HW252001
DRUG: Placebo

Sponsor

Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.